Advanced Business Development Course 2010
Munich, Germany (November 12-14, 2010)
Take your skills to the next level by working directly with colleagues in a hands-on, practical course that uses a realistic business case!
The Advanced Business Development Course is designed for business development professionals interested in bringing their skills in valuation, due diligence, negotiation and contracts to the next level. During this intense, three-day session attendees will receive hands-on, advanced training from veteran business development professionals and legal advisers using real world case studies. In addition, attendees will be split into two teams to conduct a mock negotiation over a clinical stage compound.
Since 2004, this course has been taught exclusively for life science business development professionals by the Biotechnology Industry Organization in collaboration with EBD Group. The faculty is drawn from among the most experienced business development professionals in the biotech drug development industry as well as big pharma, many of whom have been instructors in other programs, and all of whom have hands-on experience in the biotech industry.
The course will cover basic topics and skills crucial to every business development professional in the industry, including:
* Valuation Skills
* Intellectual Property
* Due Diligence
* Negotiation and Influence Strategies
Who should attend?
Although this course is recommended for business development professionals with approximately 3-5 years experience, people with less experience have taken it and benefited a great deal. It is designed for business development professionals who have most likely served as part of a business development or licensing team, but are now preparing to move to a senior manager level role within their organization.
* Business development & licensing professionals
* Alliance management professionals
* R&D personnel who have significant interaction with business development
* Intellectual property personnel involved in the licensing process
* Biotech company CEOs
Attendance is limited to 75 participants to ensure the optimal instructor/student ratio and quality interaction.
Doporučujeme
WebArchiv
